Research & Development
Our Research and Development (R&D) division drives our industry positioning as a leading pharmaceutical solutions provider in the US and in India. It develops solutions that allow us to deliver on our purpose and vision.
We bring science and innovation together
The energy and excitement of our immersion in drug development and discovery is what fuels Nppl’s journey as an innovation-led transnational pharmaceutical powerhouse.
Generics – (API and Finished Products)
Nppl’s generics R&D pipeline is aimed at developing a comprehensive portfolio of high entry-barrier products that address unmet patient needs. Our track record of successful ANDA filings and approvals has garnered us leadership in several chronic therapy areas such respiratory, diabetes and cardiovascular in India, and hypertension and calcium blockers in the US.
Complex Generics Research
We invest ahead of the curve to advance Nppl’s global generics R&D pipeline through significant investments in complex generic platform technologies. With the commissioning of a new global R&D hub in Pune, India, Nppl hosts one of the most advanced pharmaceutical product development and pilot plant facilities for oral, ophthalmic, dermatology and inhalation product development.
Navjeevan seva mandal, Naresh keni compound, Kandivali (W), Mumbai, Maharashtra, India
Pin Code : 400067
Email id : email@example.com
Mobile no : 8757084852